• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Real-World Evidence

Ständer Sonja, Ketz Miriam, Kossack Nils, Pignot Marc, Chavda Rajeev, Gabriel Sylvie, Disease Burden, Healthcare Resource Utilization & Treatment Pattern among Patients with Prurigo Nodularis compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. 31st EADV Congress, Milan. 2022;
Fritzsching Benedikt, Contoli Marco, Porsbjerg Celeste, Buchs Sarah, Rask Larsen Julie, Elliott Lisa, Romano Rogdriguez Mercedes, Freemantle Nick, Long-term real-world effectiveness of allergy immunotherpay in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study The Lancet Regional Health Volume 13. 2022;
O'Kelly James, Bartsch Robert, Kossack Nils, Borchert Julia, Pignot Marc, Hadji Peyman, Real-world effectiveness of osteoporosis treatments in Germany. Arch Osteoporos. 2022; 10.1007/s11657-022-01156-z.
Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Schmidt Katharina, Golam Sarowar, Stirnadel-Farrant Heide, Schwarting Andreas, Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4. 2022;
N Hunnicutt Jake, Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Georgiou Mary Elizabeth, Gairy Kerry, Prevalence of lupus nephritis among patients with systemic lupus erythematosus in Germany Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May. 2022; 10.1093/ndt/gfac071.036.
Schultze Michael, Zema C., Carroll R., Hurst M., Borchert J., Zhong Y., Krause T., Bluhmki T., Partington H., Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany. 2022;
Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Golam Sarowar, Stirnadel-Farrant Heide, Marinoska Tatjana, Schefzyk Sebastian, Schwarting Andreas, Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. DGRh 2022, Berlin, Germany 31 August–3 September. 2022;
Sedaghat-Hamedani F., Zema C., Schultze Michael, Borchert J., Zhong Y., Bluhmki T., Krause T., Schmoelders J., Meder B., Clinical and economic burden of hypertrophic obstructive cardiomyopathy in Germany DGK Herztage 29.09 – 01.10.2022. 2022; 10.1007/s00392-022-02087-y.
Ständer Sonja, Ketz Miriam, Kossack Nils, Akumo Divine, Pignot Marc, Chavda Rajeev, Gabriel Sylvie, Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared To A Benchmark In Germany: A Real-World-Evidence Claims Data Study. ISPOR Europe 2022, 6 - 9 November. 2022;
Vogelmeier Claus F., Diesing Joanna, Kossack Nils, Pignot Marc, Friedrich Felix W., COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany. International Journal of Chronic Obstructive Pulmonary Disease. 2021; 2407–2417.
Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Gairy Kerry, Levy R., Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress. 2021; 10.3205/21dgrh064.
Birkeland Kåre I., Bodegard Johan, Banerjee Amitava, Kim Dae Jung, Norhammar Anna, Eriksson Jan W., Thuresson Marcus, Okami Suguru, Ha Kyoung Hwa, Kossack Nils, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Lower cardiorenal risk with sodium glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes Obes Metab.. 2021; 23:75–85. 10.1111/dom.14189.
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.